Vimarsana
Biggest News Aggregation in the World

Page 28 - Pharma Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Group Today - Breaking & Trending Today

Alvotech and JAMP Pharma add biosimilar candidates - Vimarsana News

Alvotech and JAMP Pharma add biosimilar candidates

Alvotech and JAMP Pharma have expanded their exclusive partnership to commercialize biosimilars developed and manufactured by Alvotech.

Alvotech and JAMP Pharma Expand Exclusive Partnership - Vimarsana News

Alvotech and JAMP Pharma Expand Exclusive Partnership

Expanded partnership covers biosimilar candidates in immunology and oncology Alvotech (NASDAQ: ALVO), a global biotech company specializing in the...

Envision Pharma Group and Alucio™ partner to power next-generation scientific exchange for the life science industry - Vimarsana News

Envision Pharma Group and Alucio™ partner to power next-generation scientific exchange for the life science industry

- PMLiVE

Source: pmlive.com
Envision Pharma Group and Alucio™ Partner to Power Next-Generation Scientific Exchange for the Life Science Industry - Vimarsana News

Envision Pharma Group and Alucio™ Partner to Power Next-Generation Scientific Exchange for the Life Science Industry

San Francisco, CA and Horsham, UK (PRWEB) October 06, 2022 -- Envision Pharma Group (Envision) and Alucio today announced a global partnership to power

Source: prweb.com
Aktiv Pharma Group wins contract valued at up to $220 million to supply life-saving emergency autoinjectors to the Strategic National Stockpile - Vimarsana News

Aktiv Pharma Group wins contract valued at up to $220 million to supply life-saving emergency autoinjectors to the Strategic National Stockpile

Broomfield, CO (PRWEB) October 05, 2022 -- Aktiv Pharma Group (Aktiv) today announced a procurement contract award from the Biomedical Advanced Research and

Source: prweb.com